Publications by authors named "Akosua Osei-Tutu"
Article Synopsis
- Scientists created a new tool called EpiClass to help improve cancer detection through blood tests by analyzing special DNA patterns.
- This tool uses data from ovarian cancer samples and can tell if a blood sample has signs of cancer.
- EpiClass was tested on actual blood samples and showed really good results, correctly identifying cancer in almost all cases while not wrongly identifying healthy samples.
Despite high initial response rates with cytoreductive surgery, conventional chemotherapy and the incorporation of biologic agents, ovarian cancer patients often relapse and die from their disease. New approaches are needed to improve patient outcomes. This study was designed to evaluate the antitumor activity of NEO-201 monoclonal antibody (mAb) in preclinical models of ovarian cancer where the NEO-201 target is highly expressed.
View Article and Find Full Text PDF